[an error occurred while processing this directive] | [an error occurred while processing this directive]
Clinical efficacy and safety of simultaneous integrated boost intensity-modulated radiotherapy to the tumor center in the first course radiotherapy for bulky cervical cancer with massive bleeding
Ma Jun,Song Wei,Huang Wei,Yu Dahai
Department of Radiotherapy, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China
AbstractObjective To evaluate the clinical efficacy and safety of simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) to the tumor center in the treatment of bulky cervical cancer with massive bleeding in the first course radiotherapy. Methods Twenty-one cases with bulky cervical cancer complicated with massive vaginal bleeding were enrolled. At the first three times of external irradiation, a high dose radiotherapy (15 Gy/3 fractions) was delivered to the tumor center (the region retracted 2 cm from the periphery of cervical mass), followed by conventional irradiation (2 Gy/fraction) in the posterior course. Conventional dose irradiation (46 Gy/23 fractions) was given to the tumor periphery and pelvic lymphatic drainage area throughout the whole course. Concurrent chemotherapy by cisplatin at a dose of 25 mg/m2 was delivered weekly. After the external irradiation, intracavitary radiotherapy was given (20 Gy/4 fractions). Results Within 24 h after the first course radiotherapy, the volume of vaginal bleeding was significantly decreased by 50% and the bleeding was almost stopped within one week. The hemostasis rate was 100%. Conclusions SIB-IMRT into the center of bulky cervical cancer is an efficacious treatment of massive vaginal bleeding.
Ma Jun,Song Wei,Huang Wei et al. Clinical efficacy and safety of simultaneous integrated boost intensity-modulated radiotherapy to the tumor center in the first course radiotherapy for bulky cervical cancer with massive bleeding[J]. Chinese Journal of Radiation Oncology, 2019, 28(3): 193-197.
Ma Jun,Song Wei,Huang Wei et al. Clinical efficacy and safety of simultaneous integrated boost intensity-modulated radiotherapy to the tumor center in the first course radiotherapy for bulky cervical cancer with massive bleeding[J]. Chinese Journal of Radiation Oncology, 2019, 28(3): 193-197.
[1] Chen WQ,Zheng RSu,Peter DB,et al. Cancer statistic in china,2015[J].CA Cancer J Clin,2016,2(66):115-132.DOI:10.3322/caac.21338. [2] 殷蔚博,余子豪,徐国镇.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2008:1024-1025. Yin WB,Yu ZH,Xu GZ.Radiation Oncology[M].Beijing:Chines union medical university press,2008:1024-1025. [3] Lim K, Small W Jr, Portelance L,et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer[J].Int J Radiat Oncol Biol Phys,2011,79(2):348-355.DOI:10.1016/j.ijrobp.2009.10.075. [4] 谢幸,苟文丽.妇产科学(第八版)[M].北京:人民卫生出版社,2014:212. Xie X,Gou WL.Obstetrics and Gynecology (8 ed)[M].Beijing:People′s health press,2014:212. [5] Gill BS,Kim H,Houser CJ,et al. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer:the university of pittsburgh experience[J].Int J Radi Oncol Biol Phys,2015,91(3):540-547.DOI:10.1016/j.ijrobp.2014.10.153. [6] 李岚,张凯恋,张芬,等.调强放疗同期顺铂治疗晚期宫颈癌临床疗效和毒副反应观察[J].临床医药实践,2015,8(24):563-566.DOI:10.16047/j.cnki.cn14-1300/r.2015.08.001. Li L,Zhang KL,Zhang F,et al. Clinical efficacy and adverse reactions of cisplatin in the treatment of advanced cervical cancer with intensity modulated radiotherapy[J].Clin Med Pract,2015,8(24):563-566.DOI:10.16047/j.cnki.cn14-1300/r.2015.08.001. [7] Hasselle MD, Rose BS,Kochanski JD,et al. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix[J].Int J Radiat Oncol,2011,80(5):1436-1445.DOI:10.1016/j.ijrobp.2010.04.041. [8] 马珺,于大海,鹿红,等.重组人促红细胞生成素联合放疗对消化道肿瘤的疗效[J].中国新药与临床杂志,2014,33(12):890-893. Ma J,Yu DH,Lu H,et al. Effect of recombinant human erythropoietin combined with radiotherapy on digestive tract tumors[J].Chin J New Drugs Clin,2014,33(12):890-893. [9] Takagi K,Akashi K,Horiuchi I,et al. Managing vulvovaginal hematoma by arterial embolization as first-line hemostatic therapy[J].Taiwan J Obstet Gynecol,2017,56(2):224-226.DOI:10.1016/j.tjog.2016.03.009. [10] Albu S, Crigoriu C, Vasiliu C, et al. The role of uterine artery embolization in cervical cancer-single case report[J].Maedica,2011,6(2):137-140. [11] Straube C, Pigorsch SU, Scherb H, et al. Reduced volume SIBIMRT/IGRT to head and neck cancer in elderly and frail patients: outcome and toxicity[J]Radiat Oncol,2016,11:133.DOI:10.1186/s13014-016-0711-x [12] 徐裕金,刘冠,王准,等.局部晚期非小细胞肺癌同步加量调强放疗的回顾性分析[J].中华放射医学与防护杂志,2013,33(2):146-150.DOI:10.3760/cma.j.issn.0254-5098.2013.02.009. Xu YJ,Liu G,Wang H,et al. Retrospective analysis of synchronous plus intensity modulated radiotherapy for locally advanced non-small cell lung cancer[J].Chin J Radiol Med Protect,2013,33(2):146-150.DOI:10.3760/cma.j.issn.0254-5098.2013.02.009. [13] 白文文,宋玉芝,刘明,等.SIB-IMRT技术在颈及胸上段食管癌中的临床应用[J].中华肿瘤防治杂志,2016,23(4):248-252.DOI:10.16073/j.cnki.cjcpt.2016.04.010. Bai WW,Song YZ,Liu M,et al. Clinical application of SIB-IMRT technique in cervical and thoracic esophageal carcinoma[J].Chin J Oncol Prevet Treat,2016,23(4):248-252.DOI:10.16073/j.cnki.cjcpt.2016.04.010. [14] 陈冉,劝循凤,陈香存.淋巴结阳性宫颈癌患者同步整合和序贯加量调强放疗的剂量学比较[J].安徽医学,2017,38(6):713-716.DOI:10.3969/j.issn.1000-0399.2017.06.010. Chen R,Quan XF,Chen XC.Dosimetry comparison of synchronous integration and sequential plus intensity modulated radiotherapy in patients with lymph node positive cervical cancer[J].Anhui Med,2017,38(6):713-716.DOI:10.3969/j.issn.1000-0399.2017.06.010. [15] Rasool MT,Manzoor NA,Mustafa SA,et al. Hypofractionated radiotherapy as local hemostatic agent in advanced cancer[J].Indian J Palliat Care,2011,17(3):219-221.DOI:10.4103/0973-1075.92339. [16] Kosugi T, Shikama N, Saito T, et al. A Nationwide Survey in Japan of Palliative Radiotherapy for Bleeding in Gastrointestinal and Genitourinary Tumor Patients[J].World J Oncol,2016,7(2-3):29-33.DOI:10.14740/wjon977w.
2019, Vol. 28 
